ArticleJCO precision oncology2025

Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

Nina U Gelineau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.